Artrya

23/09/2021

Our innovative diagnostic support solution detects coronary artery disease. Artyra has commenced our first market pilot with Perth-based radiology practice Envision Medical Imaging. Read more in this article just published by Hospital + Healthcare Magazine. Contact us to become a trial site.

Artrya's non-invasive diagnostic support solution to detect coronary artery disease has commenced its first market pilot with Perth-based radiology practice Envision Medical Imaging.

21/09/2021

Using AI to detect what is time-consuming and challenging for the human eye to see alone, our solution can detect an unprecedented combination of coronary artery disease biomarkers in patients: vulnerable plaque, total plaque burden, stenosis severity and calcium score.

By providing key biomarker findings early in the diagnostic pathway, our AI technology unlocks the capability for you to triage patients into risk categories, quickly identifying which patients require further clinical intervention. We're revolutionising the speed and accuracy of coronary artery disease diagnosis. Contact us to discuss the opportunity to become our next pilot site.

17/09/2021

is happening now. Check out Dr. Abdul Ihdayhid's webinar discussing CT Coronary Angiography: Looking Beyond Stenosis sponsored by Artrya. Visit our booth to watch on-demand.

16/09/2021

The RANZCR2021 Virtual Conference is starting today. For the first time, we are showcasing our ground-breaking technology, Salix, which is now in pilot at an Australian radiology practice. Register your interest to trial automatic coronary artery disease detection by visiting our virtual booth!

Salix is a non-invasive solution that illustrates vulnerable plaque and biomarkers of coronary artery disease. Read on to learn more about our AI software.

14/09/2021

Artrya is making its debut at the RANZCR2021 Virtual Conference, starting this Thursday 16 September, where we'll make an exciting announcement. We look forward to seeing you online! Artrya: Detecting Coronary Heart Disease with AI

08/09/2021

Artrya is proud to launch our new website! Harnessing the power of artificial intelligence, our health-tech solution supports referring and reporting clinicians in the diagnosis of coronary artery disease. Our automated Software as a Medical Device (SaMD) can detect and assess an unprecedented combination of key coronary heart disease biomarkers, enabling rapid patient triage and targeted therapy. Whether you're a Cardiologist or Radiologist, you'll be interested to learn more about our commercialisation progress. We’re changing how the world sees coronary artery disease. Visit our new site!

Artrya Salix lets you see heart disease in a new way. Our artificial intelligence solution detects coronary artery disease (CAD) biomarkers quickly and accurately. Find out more.